Contradictive evidence regarding the isocitrate dehydrogenase 1 (IDH1) status in primary paediatric glioblastomas suggested that almost all cases within young children were IDH-wild type, whereas an adolescent’s cohort with secondary paediatric GBM presented with an IDH-mutant molecular profile [7,8]. This evidence concerns the gene IDH1 and glioblastoma.